Vimarsana
Biggest News Aggregation in the World

Mortality Risk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mortality Risk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mortality Risk Today - Breaking & Trending Today

BBCNEWS BBC July 2, 2024 - Vimarsana News

BBCNEWS BBC July 2, 2024

things economically, there is always huge scope to cut or raise taxes, or spending, and then there is what his room for manoeuvre is within his self—imposed targets. we must be clear on this. a government's finances are completely unlike a household finance. we live in a currency where the government issues currency, we cannot do that, ferns cannot do that, whereas the government issues a currency and has a lot more freedom than us. not many of us have a money printing press in our front rooms. of us have a money printing press in ourfront rooms. but of us have a money printing pre...

Study Suggests Hearing Aids Lower Cognitive Decline and Mortality Risk - Vimarsana News

Study Suggests Hearing Aids Lower Cognitive Decline and Mortality Risk

Adults with hearing loss who regularly use hearing aids have a 24 percent lower mortality risk.

Common mental health problem can shorten cancer survivors' lives, study finds: 'Critical issue' - Vimarsana News

Common mental health problem can shorten cancer survivors' lives, study finds: 'Critical issue'

Cancer survivors who feel lonely tend to have a greater risk of dying, according to research from the American Cancer Society. Researchers and mental health experts offered insights.

Source: yahoo.com
Patients Treated By Women Physicians Have Lower Mortality: Study - Vimarsana News

Patients Treated By Women Physicians Have Lower Mortality: Study

A new study of over 776,000 patients found that those who were treated by women physicians had lower mortality and readmission rates than those who consulted male physicians.

Source: forbes.com
FDA Approves Alecensa for ALK-Positive NSCLC - Vimarsana News

FDA Approves Alecensa for ALK-Positive NSCLC

The Food and Drug Administration approved Alecensa for patients with ALK-positive non-small cell lung cancer that was surgically removed.